DEXCOM INC. DL-,001/ US2521311074 /
2024-05-23 12:37:54 PM | Chg. +0.90 | Volume | Bid8:59:53 PM | Ask8:59:53 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
120.72EUR | +0.75% | 80 Turnover: 9,657.60 |
-Bid Size: - | -Ask Size: - | 46.18 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.